TREX1 and small cell lung carcinoma: Together, these data provide additional support that TREX1 induction contributes to the survival capacity of SCLC cells as a strategy to suppress an innate immune activation triggered by dsDNAs derived from DNA-damaging agents (Fig. 4I), but additional mechanisms will play a role in SCLC chemoresistance, which will warrant further investigation.